In conclusion, the present study showed that serum HMGB1 levels were increased in patients with hyperlipidemia, and that atorvastatin reduces serum HMGB1 levels which may be attributed to the decrease in serum lipids. Here, HMGB1 is linked to hyperlipidemia.